POINT: Do Randomized Controlled Trials Ignore Needed Patient Populations? Yes

Chest

Volumn 149, Issue 5, 2016, Pages 1128-1130

  Courtright, Katherine ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CLINICAL RESEARCH; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; MINORITY GROUP; MULTIPLE CHRONIC CONDITIONS; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); CRITICAL ILLNESS; FEMALE; MALE; PATIENT SELECTION; PROCEDURES;

CRITICAL ILLNESS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84966462037     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.01.029     Document Type: Editorial

References (20)

1. Cohen, A.M., Stavri, P.Z., Hersh, W.R., A categorization and analysis of the criticisms of evidence-based medicine. Int J Med Inform 73:1 (2004), 35–43.
2. Hennekens, C.H., Eberlein, K., A randomized trial of aspirin and beta-carotene among US physicians. Prev Med 14:2 (1985), 165–168.
3. Carson, P., Ziesche, S., Johnson, G., Cohn, J.N., Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. J Card Fail 5:3 (1999), 178–187.
4. Ferguson, J.F., Patel, P.N., Shah, R.Y., et al. Race and gender variation in response to evoked inflammation. J Transl Med, 11, 2013, 63.
5. Lederer, D.J., Arcasoy, S.M., Barr, R.G., et al. Racial and ethnic disparities in idiopathic pulmonary fibrosis: a UNOS/OPTN database analysis. Am J Transplant 6:10 (2006), 2436–2442.
6. Barnato, A.E., Alexander, S.L., Linde-Zwirble, W.T., Angus, D.C., Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med 177:3 (2008), 279–284.
7. Bernard, G.R., Vincent, J.L., Laterre, P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:10 (2001), 699–709.
8. King, T.E. Jr., Bradford, W.Z., Castro-Bernardini, S., et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370:22 (2014), 2083–2092.
9. Wendler, D., Kington, R., Madans, J., et al. Are racial and ethnic minorities less willing to participate in health research?. PLoS Med, 3(2), 2006, e19.
10. Hussain-Gambles, M., Atkin, K., Leese, B., Why ethnic minority groups are under-represented in clinical trials: a review of the literature. Health Soc Care Community 12:5 (2004), 382–388.
11. Heiat, A., Gross, C.P., Krumholz, H.M., Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 162:15 (2002), 1682–1688.
12. Herrera, A.P., Snipes, S.A., King, D.W., Torres-Vigil, I., Goldberg, D.S., Weinberg, A.D., Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am J Public Health 100:suppl 1 (2010), S105–S112.
13. Scott, I.A., Guyatt, G.H., Cautionary tales in the interpretation of clinical studies involving older persons. Arch Intern Med 170:7 (2010), 587–595.
14. Hutchins, L.F., Unger, J.M., Crowley, J.J., Coltman, C.A. Jr., Albain, K.S., Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:27 (1999), 2061–2067.
15. National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:5 (2011), 395–409.
16. Pinsky, P.F., Gierada, D.S., Hocking, W., Patz, E.F. Jr., Kramer, B.S., National lung screening trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med 161:9 (2014), 627–633.
17. Medicare Coverage Database: Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N) Feb 5 2015. Centers for Medicare & Medicaid Services website. https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274. Accessed October 11, 2015.
18. Lehnert, T., Heider, D., Leicht, H., et al. Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev 68:4 (2011), 387–420.
19. Coca, S.G., Krumholz, H.M., Garg, A.X., Parikh, C.R., Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296:11 (2006), 1377–1384.
20. Davis, S., Wright, P.W., Schulman, S.F., et al. Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials. Cancer 56:7 (1985), 1710–1718.